Related Experiment Videos
Immunospecific vesicle targeting facilitates microinjection into lymphocytes.
Summary
Antibody-targeted vesicles significantly improve cell fusion and microinjection efficiency. This method enables precise delivery into specific cell types, enhancing experimental outcomes.
Area of Science:
- Biotechnology
- Cell Biology
- Immunology
Background:
- Polyethylene glycol (PEG)-mediated fusion is a common method for introducing substances into cells.
- Achieving efficient and specific cell microinjection remains a challenge, particularly for certain cell types like lymphocytes.
- Targeting strategies are crucial for directing cellular delivery systems to desired cell populations.
Purpose of the Study:
- To develop and evaluate an antibody-directed method for enhancing vesicle fusion and microinjection into specific cells.
- To demonstrate the efficacy of targeted delivery compared to non-targeted methods using polyethylene glycol (PEG).
- To establish a versatile technique for efficient cellular microinjection in various cell types.
Main Methods:
- Erythrocyte ghosts containing fluorescent bovine serum albumin were prepared.
- Targeting involved labeling cells with biotin-modified antibodies followed by incubation with avidin-coupled erythrocyte ghosts.
- The fusion and microinjection efficiency of targeted vesicles was assessed in murine spleen and thymus cells, and in lymphocyte, monocyte, and fibroblast cell lines.
Main Results:
- Antibody-directed targeting dramatically enhanced polyethylene glycol (PEG)-mediated fusion and microinjection.
- Targeted cell populations exhibited substantial levels of microinjection.
- Cells treated with PEG without targeting showed no significant microinjection.
Conclusions:
- Antibody-directed vesicle targeting is a highly effective strategy for enhancing cell microinjection.
- This method offers precise delivery to specific cell populations, including challenging cell types like lymphocytes.
- The technique improves injection efficiencies, making it valuable for targeted cellular delivery and when reagent use is limited.